bioMérieux S.A. (BIM.PA)

Paris · Healthcare · Diagnostics & Research
€91.30+0.16%As of 2026-11-22 · EUR
Last session low €91.35Last session high €92.45
52-week low €65.6052-week high €116.10
Market cap (USD)
$11.82B
Sector
Healthcare
P/E (TTM)
23.4x
Dividend yield
1.07%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in EUR.

IndicatorValueReading
RSI (14)56.9In the neutral range (30 to 70)
MACD (12, 26, 9)1.72Below its signal line (2.41); histogram -0.69
Bollinger %B (20, 2)42%Inside the bands (87.88 to 95.94)
SMA 2091.91Price is 0.7% below
SMA 5084.73Price is 7.8% above
SMA 20079.75Price is 14.5% above
ATR (20)2.17% of priceAverage true range per day
52-week position51%In the middle of the 65.60 to 116.10 range

About bioMérieux S.A.

bioMérieux S.A. develops, manufactures, and markets in vitro diagnostic solutions for infectious diseases in France, Europe, Africa, the Middle East, North and South America, the Asia Pacific, and internationally. It operates through Clinical Applications and Industrial Applications segments.

Latest fiscal yearEnded 2025-12-31: revenue of 4.07B EUR and an operating margin of 17.1%.

More in Diagnostics & Research